Marker Therapeutics, Inc. (MRKR)
1.49
+0.02
(+1.36%)
USD |
NASDAQ |
Dec 31, 16:00
1.48
-0.01
(-0.67%)
After-Hours: 20:00
Marker Therapeutics Free Cash Flow: -14.82M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics, Inc. | 40.61M |
| Neurocrine Biosciences, Inc. | 593.10M |
| AIM ImmunoTech, Inc. | -13.33M |
| Protalix Biotherapeutics, Inc. | -11.69M |
| Armata Pharmaceuticals, Inc. | -27.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.736M |
| Cash from Financing (Quarterly) | 9.864M |
| Free Cash Flow Per Share (Quarterly) | -0.1633 |
| Free Cash Flow to Equity (Quarterly) | -2.736M |
| Free Cash Flow to Firm (Quarterly) | -2.736M |
| Free Cash Flow Yield | -78.12% |